Table 1.
The objectives for the five phases of monitoring
| Phase | Monitoring objectives | Optimal interval |
|---|---|---|
| Pretreatment | Check need for treatment Establish a baseline for determining response and change | Short—based on variability within patients |
| Initial titration | Assess individual response to treatment Assess immediate adverse effects Achieve control | Medium—based on pharmacokinetics (such as drug half life) and pharmacodynamics (physiological impact time) (wash-in) |
| Maintenance | Detect drift from control limits Detect long term harms | Long—based on rate of random and systematic “drift” |
| Re-establish control | Bring level back within control limits | Medium—as above |
| Cessation | Check safety of cessation | Medium—as above |